Katarina Mars

Publications
Public outreach and news

Articles

Article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2025;10(8):708-718
Effects of beta-blockers on quality of life and well-being in patients with myocardial infarction and preserved left ventricular function-a prespecified substudy from REDUCE-AMI
Mars K; Humphries S; Leissner P; Jonsson M; Karlstrom P; Lauermann J; Alfredsson J; Kellerth T; Ravn-Fischer A; Erlinge D; Lindahl B; Yndigegn T; Jernberg T; Held C; Olsson EMG; Hofmann R
Article: EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE. 2024;13(11):789-797
Short- and long-term effects of beta-blockers on symptoms of anxiety and depression in patients with myocardial infarction and preserved left ventricular function: a pre-specified quality of life sub-study from the REDUCE-AMI trial
Leissner P; Mars K; Humphries S; Karlstrom P; Yndigegn T; Jernberg T; Hofmann R; Held C; Olsson EMG
Article: NEW ENGLAND JOURNAL OF MEDICINE. 2024;390(15):1372-1381
Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction
Yndigegn T; Lindahl B; Mars K; Alfredsson J; Benatar J; Brandin L; Erlinge D; Hallen O; Held C; Hjalmarsson P; Johansson P; Karlstrom P; Kellerth T; Marandi T; Ravn-Fischer A; Sundstrom J; Ostlund O; Hofmann R; Jernberg T
Article: EUROPEAN HEART JOURNAL OPEN. 2023;3(3):oead036
Randomized evaluation of routine beta-blocker therapy after myocardial infarction quality of life (RQoL): design and rationale of a multicentre, prospective, randomized, open, blinded endpoint study.
Humphries S; Mars K; Hofmann R; Held C; Olsson EMG
Article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2023;9(2):192-197
Design and rationale of randomized evaluation of decreased usage of beta-blockers after acute myocardial infarction (REDUCE-AMI)
Yndigegn T; Lindahl B; Alfredsson J; Benatar J; Brandin L; Erlinge D; Haaga U; Held C; Johansson P; Karlstrom P; Kellerth T; Marandi T; Mars K; Ravn-Fischer A; Sundstrom J; Ostlund O; Hofmann R; Jernberg T
Article: EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE. 2022;11(6):491-500
Association between β-blocker dose and quality of life after myocardial infarction: a real-world Swedish register-linked study
Humphries S; Wallert J; Mars K; Held C; Hofmann R; Olsson EMG
Article: AMERICAN HEART JOURNAL. 2021;237:13-24
Randomized comparison of early supplemental oxygen versus ambient air in patients with confirmed myocardial infarction: Sex-related outcomes from DETO2X-AMI
Alfredsson J; James SK; Erlinge D; Herlitz J; Frobert O; Dworeck C; Redfors B; Arefalk G; Ostlund O; Jernberg T; Mars K; Haaga U; Lindahl B; Swahn E; Lawesson SS; Hofmann R
Article: EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE. 2021;10(4):372-379
Association between β-blocker dose and cardiovascular outcomes after myocardial infarction: insights from the SWEDEHEART registry
Mars K; Wallert J; Held C; Humphries S; Pingel R; Jernberg T; Olsson EMG; Hofmann R
Article: AMERICAN HEART JOURNAL. 2021;231:105-109
Helicobacter pylori screening in clinical routine during hospitalization for acute myocardial infarction
Waerme J; Sundqvist M; Mars K; Aladellie L; Pawelzik S-C; Erlinge D; Jernberg T; James S; Hofmann R; Baeck M

All other publications

Preprint: SSRN ELECTRONIC JOURNAL. 2021
Association Between β-Blocker Dose with Quality of Life after Myocardial Infarction
Humphries SM; Wallert J; Mars K; Held C; Hofmann R; Olsson E
Conference publication: HELICOBACTER. 2020;25:4-5
Helicobacter pylori screening in patients with acute myocardial infarction
Hofmann R; Warme J; Sundqvist M; Mars K; Aladellie L; Back M

Articles

All other publications

News from KI

Events from KI